US EditionPublished • loading... • Updated
NEXGEL Appoints Ian Blackman CFO Amid Celularity Deal
Summary by MyChesCo
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
NEXGEL Appoints Ian Blackman CFO Amid Celularity Deal
LANGHORNE, PA — NEXGEL, Inc. (Nasdaq: NXGL) recently appointed Ian Blackman as chief financial officer as the company works to complete a planned acquisition of regenerative biomaterial assets from Celularity Inc. (Nasdaq: CELU), the company announced. Blackman will help advance the closing of a definitive agreement to license and acquire a portfolio of commercial-stage products from Celularity, according to the announcement. Chief Executive Off…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
